Dr Bhadrappa added that approximately 15 percent of prostate cancer cases fall into the high-risk category. He said, “These are more aggressive, with a greater chance of becoming life-threatening.

The Gleason score is the histopathologic grading system for assessing the architectural patterns of prostate cancer cells in biopsies. The scores range from 6 to 10, and higher values indicate ...

The prostate cancer patients were on average 63 (±6.3) years old at diagnosis. For 242 (65%) patients, the PSA value at diagnosis was below 10 ng/ml; the clinical stage was classified as T1-T2a ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A Gleason score is a system physicians use to grade prostate cancer based on how abnormal the cancer cells look under a microscope. Generally, the higher the score, the more aggressive the cancer is.

The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 7: Non-metastatic ...

Illuccix® (kit for the preparation of gallium-68 ( 68 Ga) gozetotide injection), Telix's first generation PSMA-PET imaging ...

According to the EAU-ESTRO-SIOG 2018 guidelines, the biochemical disease-free survival for Gleason 6 prostate cancer at 5 years ranges from 71-93% and at 10 years from 65-85%.

Illuccix, a preparation kit for injectable Ga-68, has been approved to select patients for radioligand therapy before taxane ...

Diffusion basis spectrum imaging combined with AI enhances diagnostic accuracy for prostate cancer A study published in the ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

Jason Junkins, M.D., and his wife, Angela For local urgent care physician Jason Junkins, M.D., prostate cancer was not on his ...